CVS’ Aetna To Meld Cancer Treatment Approvals As Insurers Cut Hurdles
Direct Source Verification:
This story is aggregated from Forbes (forbes.com). Full reporting rights and copyright belong to the primary publisher.
CVS Health’s Aetna will bundle cancer treatments into a single clinical review as the industry works to further eliminate the controversial prior authorization process.
For complete coverage, context, and related multimedia, visit the original reporting by Forbes via the source link below.
Original Source
https://www.forbes.com/sites/brucejapsen/2026/09/17/cvs-aetna-to-meld-cancer-treatment-approvals-as-insurers-cut-hurdles/
